St. Joseph's Health Care
London, Ontario, N6A 4V2, Canada
NCT Number: NCT01260233
The purpose of this study is to determine whether a perioperative smoking cessation program, implemented at least 3 weeks prior to elective surgery, is effective in increasing rates of smoking cessation or reduction. Intraoperative and immediate postoperative complications will also be compared.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
London, Ontario, N6A 4V2, Canada
Previous studies have shown that patients have up to one-third fewer complications after surgery when they quit smoking at least several weeks before surgery. Nicotine replacement therapy (which relieves cravings for cigarettes) and support by healthcare professionals have been shown to help patients quit smoking, particularly when encountering a major health event (e.g. surgery). In addition, quitting smoking in preparation for surgery sometimes results in quitting for a longer period of time after surgery, giving these patients the health benefits of long-term smoking cessation such as reduced rates of cancer and heart disease.
The preadmission clinic at St. Joseph's Health Care, London, Ontario, is assessing how effective a new 'Stop Smoking' program is for patients preparing for surgery. The program will include brief counselling in the clinic, smoking cessation brochures, six weeks of free transdermal nicotine replacement therapy and a referral to the Canadian Cancer Society's Smokers' Helpline telephone advice line. Patients that are smokers and preparing for their elective surgery will be invited to join the study, then be assigned to a group that either participates in the program or not. These groups will then be compared in terms of success at quitting smoking and complication rates around the time of surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Smoking cessation program includes:
Other names: nicoderm, transdermal nicotine replacement therapy, nicotine replacement patch
Time frame: date of surgery
Smoking cessation is defined as exhaled carbon monoxide (CO) of equal to or less than 7ppm on the day of surgery.
Time frame: day of surgery
Smoking cessation/reduction by self-report. Smoking cessation defined as zero cigarettes in the 7 days before surgery (but exhaled CO > 7ppm) Reduction defined as 50% or less of initial self-report.
Time frame: day of surgery
Events occurring in the operating room or post-anesthetic care unit (PACU) as reported by a blinded anesthesiologist or blinded PACU nurse:
Cardiovascular complications, Respiratory complications, Other (detailed description exceeds character limits)
Time frame: day of surgery
The time of arrival in PACU until the time the patient is deemed ready for discharge in accordance with hospital routine scoring system. The actual time spent in PACU (arrival until discharge) will also be compared.
Patients bypassing PACU (e.g. patients having only sedation transferred directly from the operating room to surgical daycare prior to discharge home) will be considered separately.
Time frame: day of surgery
Patient booked as one-day stay, but later admitted to inpatient ward.
Time frame: until hospital discharge
For inpatients only, the time from admission to surgical daycare until the patient is discharged home from the hospital.
Time frame: 1 year
Self-reported smoking zero cigarettes in the 7 days prior to phone call. Phone call will occur at any time during the 12th month after surgery.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
The Effect of a Perioperative Smoking Cessation Program on Rates of Smoking Cessation/Reduction and Perioperative Complications: a Randomized Clinical Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03259360
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT03194958
Behavior, Behavior, Addictive
St Louis, Missouri, United States
View Trial DetailsNCT03645941
Behavior, Cigarette Smoking
Rochester, Minnesota, United States
View Trial DetailsNCT04979013
Behavior, Health Behavior
Lincoln, Nebraska, United States
View Trial Details